← Back to Search

iTEAR100 Therapy for Dry Eye Syndrome

Phase 4
Waitlist Available
Research Sponsored by Olympic Ophthalmics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Inclusion Criteria: Able to sign English language consent form and over age 18 and reside in the U.S.
-
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

A Usability Study of External Neuromodulation With iTEAR100 Generation 2. A study which evaluates user ability to train and access the iTEAR100 device in a telehealth environment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Usability
Secondary outcome measures
Adverse Events
Symptom Score
Symptom Scores

Trial Design

1Treatment groups
Experimental Treatment
Group I: iTEAR100 TherapyExperimental Treatment1 Intervention
Treatment Arm. Assessment of usability of generation 2 connected devices

Find a Location

Who is running the clinical trial?

Olympic Ophthalmics, Inc.Lead Sponsor
3 Previous Clinical Trials
265 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~32 spots leftby May 2025